1. Home
  2. SWKH vs EARN Comparison

SWKH vs EARN Comparison

Compare SWKH & EARN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SWKH
  • EARN
  • Stock Information
  • Founded
  • SWKH 1996
  • EARN 2012
  • Country
  • SWKH United States
  • EARN United States
  • Employees
  • SWKH N/A
  • EARN N/A
  • Industry
  • SWKH Diversified Financial Services
  • EARN Real Estate Investment Trusts
  • Sector
  • SWKH Finance
  • EARN Real Estate
  • Exchange
  • SWKH Nasdaq
  • EARN Nasdaq
  • Market Cap
  • SWKH 202.7M
  • EARN 187.6M
  • IPO Year
  • SWKH 1999
  • EARN 2013
  • Fundamental
  • Price
  • SWKH $17.11
  • EARN $6.52
  • Analyst Decision
  • SWKH
  • EARN Hold
  • Analyst Count
  • SWKH 0
  • EARN 1
  • Target Price
  • SWKH N/A
  • EARN N/A
  • AVG Volume (30 Days)
  • SWKH 6.8K
  • EARN 755.8K
  • Earning Date
  • SWKH 03-20-2025
  • EARN 03-05-2025
  • Dividend Yield
  • SWKH N/A
  • EARN 14.72%
  • EPS Growth
  • SWKH N/A
  • EARN 277.67
  • EPS
  • SWKH 0.84
  • EARN 1.02
  • Revenue
  • SWKH $24,725,000.00
  • EARN N/A
  • Revenue This Year
  • SWKH N/A
  • EARN N/A
  • Revenue Next Year
  • SWKH $6.17
  • EARN $89.08
  • P/E Ratio
  • SWKH $20.40
  • EARN $6.37
  • Revenue Growth
  • SWKH N/A
  • EARN N/A
  • 52 Week Low
  • SWKH $15.14
  • EARN $5.88
  • 52 Week High
  • SWKH $18.49
  • EARN $7.26
  • Technical
  • Relative Strength Index (RSI)
  • SWKH 61.49
  • EARN 46.33
  • Support Level
  • SWKH $16.42
  • EARN $6.46
  • Resistance Level
  • SWKH $17.25
  • EARN $6.60
  • Average True Range (ATR)
  • SWKH 0.23
  • EARN 0.10
  • MACD
  • SWKH 0.06
  • EARN -0.00
  • Stochastic Oscillator
  • SWKH 88.71
  • EARN 38.10

About SWKH SWK Holdings Corporation

SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment.

About EARN Ellington Residential Mortgage REIT of Beneficial Interest

Ellington Credit Co is focused on corporate collateralized loan obligations (CLOs). It focuses on acquiring, investing in, and managing secondary CLO mezzanine debt and equity tranches. The company relies on strong risk management, including disciplined liquidity management and selective use of credit hedges, to preserve book value during times of stress. It also leverages Ellington's proprietary technology, analytics and risk management systems to enhance underwriting and investment selection and to guide ongoing portfolio monitoring and surveillance.

Share on Social Networks: